Literature DB >> 1476758

The objective response of brain metastases on radiotherapy. A prospective study using computer tomography.

E van der Steen-Banasik1, J Hermans, R Tjho-Heslinga, R Caspers, J W Leer.   

Abstract

A prospective study was performed to establish the objective response of brain metastases after radiotherapy. Twenty-five patients with a total of 53 metastatic lesions were evaluated approximately 6 weeks after completing the treatment (30 Gy/2,5 weeks). Clinical response was seen more often than objective response, due probably to concomitant use of corticosteroids and to most patients having multiple metastases. Clinical response, although important for the patient, does not well reflect the objective response. In 48% of the cases there was agreement between the clinical and the radiodiagnostic findings. The tumor size was an important prognostic factor for prediction of complete response. The majority of patients who achieved complete remission of at least one of the metastatic lesions, did not show recurrence of the neurological symptoms.

Entities:  

Mesh:

Year:  1992        PMID: 1476758     DOI: 10.3109/02841869209083870

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  3 in total

1.  Radiotherapy response of cerebral metastases quantified by serial MR imaging.

Authors:  E J Zijlstra; M J Taphoorn; F Barkhof; F G Hoogenraad; J J Heimans; J Valk
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

2.  Local recurrence and cerebral progression-free survival after multiple sessions of stereotactic radiotherapy of brain metastases: a retrospective study of 184 patients : Statistical analysis.

Authors:  Laure Kuntz; Clara Le Fèvre; Delphine Jarnet; Audrey Keller; Philippe Meyer; Caroline Bund; Isabelle Chambrelant; Delphine Antoni; Georges Noel
Journal:  Strahlenther Onkol       Date:  2022-03-16       Impact factor: 4.033

3.  Hippocampal avoidance whole-brain radiotherapy without memantine in preserving neurocognitive function for brain metastases: a phase II blinded randomized trial.

Authors:  Wen-Chi Yang; Ya-Fang Chen; Chi-Cheng Yang; Pei-Fang Wu; Hsing-Min Chan; Jenny Ling-Yu Chen; Guann-Yiing Chen; Jason Chia-Hsien Cheng; Sung-Hsin Kuo; Feng-Ming Hsu
Journal:  Neuro Oncol       Date:  2021-03-25       Impact factor: 12.300

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.